Kamp, J.C.; Fuge, J.; Ringshausen, F.C.; Grote-Koska, D.; Brand, K.; Graalmann, L.; Vonberg, R.-P.; Welte, T.; Rademacher, J.
Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial. Antibiotics 2021, 10, 292.
https://doi.org/10.3390/antibiotics10030292
AMA Style
Kamp JC, Fuge J, Ringshausen FC, Grote-Koska D, Brand K, Graalmann L, Vonberg R-P, Welte T, Rademacher J.
Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial. Antibiotics. 2021; 10(3):292.
https://doi.org/10.3390/antibiotics10030292
Chicago/Turabian Style
Kamp, Jan C., Jan Fuge, Felix C. Ringshausen, Denis Grote-Koska, Korbinian Brand, Lukas Graalmann, Ralf-Peter Vonberg, Tobias Welte, and Jessica Rademacher.
2021. "Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial" Antibiotics 10, no. 3: 292.
https://doi.org/10.3390/antibiotics10030292
APA Style
Kamp, J. C., Fuge, J., Ringshausen, F. C., Grote-Koska, D., Brand, K., Graalmann, L., Vonberg, R.-P., Welte, T., & Rademacher, J.
(2021). Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial. Antibiotics, 10(3), 292.
https://doi.org/10.3390/antibiotics10030292